Regulus Therapeutics and GlaxoSmithKline Establish New Collaboration to …
MarketWatch (press release)
Regulus Therapeutics Inc. today announced the establishment of a new collaboration with GlaxoSmithKline (GSK) to develop and commercialize microRNA …
Market Report — In Play (GSK)
MSN Money
GlaxoSmithKline and Regulus Therapeutics establish new collaboration to develop and commercialize microRNA Therapeutics Targeting miR-122 Co and Regulus …
Regulus, the MicroRNA Child of Isis and Alnylam, Strikes Potential $150M Deal …
Xconomy
Two years have passed since GlaxoSmithKline anointed a startup called Regulus Therapeutics as a leader in the bleeding-edge world of microRNA drugs, …
Subscribe to the miRNA blog
Thank you for subscribing.
Something went wrong.
